title: Visceral leishmaniasis: a new opportunistic infection in hematopoietic stem-cell-transplanted patients.
authors.forename: A
authors.initials: A
authors.lastname: Sirvent-von Bueltzingsloewen
authors.forename: P
authors.initials: P
authors.lastname: Marty
authors.forename: E
authors.initials: E
authors.lastname: Rosenthal
authors.forename: P
authors.initials: P
authors.lastname: Delaunay
authors.forename: A
authors.initials: A
authors.lastname: Allieri-Rosenthal
authors.forename: N
authors.initials: N
authors.lastname: Gratecos
authors.forename: J P
authors.initials: JP
authors.lastname: Cassuto
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000635:transmission*; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000469:parasitology; D033581:Stem Cell Transplantation / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D000981:Antiprotozoal Agents; D000666:Amphotericin B